Filed: 11/9/2023ACC: 0001213900-23-085253
📋 What this filing means
RHENMAN & PARTNERS ASSET MANAGEMENT AB filed this quarterly 13F‑HR report disclosing 82 equity positions with a total reported market value of $928.59M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
82
Positions
$928.59M
Total AUM (reported)
15.44M
Total Shares
Allocation by class
COM$769.26M82.8%
COM NEW$70.09M7.5%
CL A COM$36.43M3.9%
SHS USD$30.34M3.3%
CL A$9.88M1.1%
SPONSORED ADS$7.56M0.8%
SHS$2.81M0.3%
Portfolio Concentration
Top 3$103.19M11.1%
4–10$193.65M20.9%
11–25$301.52M32.5%
Rest$330.23M35.6%
Top 3 weight
11.1%
Top 10 weight
32.0%
Voting Authority Distribution
Total shares with voting rights: 15.44M
Sole
Full voting authority
15.44M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole82
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings82
Rows:
DEXCOM INC
SOLEShares81K
TypeSH
Market value$37.99M
4.09%
Sole
81K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares380K
TypeSH
Market value$32.94M
3.55%
Sole
380K
Shared
0.00
None
0.00
CENCORA INC
SOLEShares114.98K
TypeSH
Market value$32.26M
3.47%
Sole
114.98K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares580K
TypeSH
Market value$31.37M
3.38%
Sole
580K
Shared
0.00
None
0.00
JAZZ PHARMACEUTICALS PLC
SOLEShares71K
TypeSH
Market value$30.34M
3.27%
Sole
71K
Shared
0.00
None
0.00
VEEVA SYS INC
SOLEShares60K
TypeSH
Market value$28.84M
3.11%
Sole
60K
Shared
0.00
None
0.00
ABBOTT LABS
SOLEShares249K
TypeSH
Market value$27.15M
2.92%
Sole
249K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares292K
TypeSH
Market value$25.73M
2.77%
Sole
292K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares35K
TypeSH
Market value$25.15M
2.71%
Sole
35K
Shared
0.00
None
0.00
BECTON DICKINSON & CO
SOLEShares95K
TypeSH
Market value$25.08M
2.70%
Sole
95K
Shared
0.00
None
0.00
DANAHER CORPORATION
SOLEShares56K
TypeSH
Market value$24.88M
2.68%
Sole
56K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares290K
TypeSH
Market value$23.60M
2.54%
Sole
290K
Shared
0.00
None
0.00
ALNYLAM PHARMACEUTICALS INC
SOLEShares119K
TypeSH
Market value$22.90M
2.47%
Sole
119K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares63.50K
TypeSH
Market value$22.35M
2.41%
Sole
63.50K
Shared
0.00
None
0.00
MCKESSON CORP
SOLEShares190K
TypeSH
Market value$21.92M
2.36%
Sole
190K
Shared
0.00
None
0.00
HCA HEALTHCARE INC
SOLEShares46K
TypeSH
Market value$20.57M
2.21%
Sole
46K
Shared
0.00
None
0.00
CENTENE CORP DEL
SOLEShares52.80K
TypeSH
Market value$20.25M
2.18%
Sole
52.80K
Shared
0.00
None
0.00
ABBVIE INC
SOLEShares150K
TypeSH
Market value$20.21M
2.18%
Sole
150K
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares64.50K
TypeSH
Market value$19.57M
2.11%
Sole
64.50K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares64.50K
TypeSH
Market value$18.37M
1.98%
Sole
64.50K
Shared
0.00
None
0.00
ESSA PHARMA INC
SOLEShares234K
TypeSH
Market value$18.03M
1.94%
Sole
234K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares145K
TypeSH
Market value$17.98M
1.94%
Sole
145K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares190K
TypeSH
Market value$17.31M
1.86%
Sole
190K
Shared
0.00
None
0.00
CHARLES RIV LABS INTL INC
SOLEShares248K
TypeSH
Market value$17.14M
1.85%
Sole
248K
Shared
0.00
None
0.00
LILLY ELI & CO
SOLEShares175K
TypeSH
Market value$16.43M
1.77%
Sole
175K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DEXCOM INCSOLE | COM | 81K | SH | $37.99M 4.09% | 81K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 380K | SH | $32.94M 3.55% | 380K | 0.00 | 0.00 |
CENCORA INCSOLE | COM | 114.98K | SH | $32.26M 3.47% | 114.98K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 580K | SH | $31.37M 3.38% | 580K | 0.00 | 0.00 |
JAZZ PHARMACEUTICALS PLCSOLE | SHS USD | 71K | SH | $30.34M 3.27% | 71K | 0.00 | 0.00 |
VEEVA SYS INCSOLE | CL A COM | 60K | SH | $28.84M 3.11% | 60K | 0.00 | 0.00 |
ABBOTT LABSSOLE | COM | 249K | SH | $27.15M 2.92% | 249K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 292K | SH | $25.73M 2.77% | 292K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 35K | SH | $25.15M 2.71% | 35K | 0.00 | 0.00 |
BECTON DICKINSON & COSOLE | COM | 95K | SH | $25.08M 2.70% | 95K | 0.00 | 0.00 |
DANAHER CORPORATIONSOLE | COM | 56K | SH | $24.88M 2.68% | 56K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 290K | SH | $23.60M 2.54% | 290K | 0.00 | 0.00 |
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 119K | SH | $22.90M 2.47% | 119K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 63.50K | SH | $22.35M 2.41% | 63.50K | 0.00 | 0.00 |
MCKESSON CORPSOLE | COM | 190K | SH | $21.92M 2.36% | 190K | 0.00 | 0.00 |
HCA HEALTHCARE INCSOLE | COM | 46K | SH | $20.57M 2.21% | 46K | 0.00 | 0.00 |
CENTENE CORP DELSOLE | COM | 52.80K | SH | $20.25M 2.18% | 52.80K | 0.00 | 0.00 |
ABBVIE INCSOLE | COM | 150K | SH | $20.21M 2.18% | 150K | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 64.50K | SH | $19.57M 2.11% | 64.50K | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 64.50K | SH | $18.37M 1.98% | 64.50K | 0.00 | 0.00 |
ESSA PHARMA INCSOLE | COM NEW | 234K | SH | $18.03M 1.94% | 234K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 145K | SH | $17.98M 1.94% | 145K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 190K | SH | $17.31M 1.86% | 190K | 0.00 | 0.00 |
CHARLES RIV LABS INTL INCSOLE | COM | 248K | SH | $17.14M 1.85% | 248K | 0.00 | 0.00 |
LILLY ELI & COSOLE | COM | 175K | SH | $16.43M 1.77% | 175K | 0.00 | 0.00 |
Page 1 of 4